Shedir Pharma Srl Unipersonale
MIL:SHE

Watchlist Manager
Shedir Pharma Srl Unipersonale Logo
Shedir Pharma Srl Unipersonale
MIL:SHE
Watchlist
Price: 4.88 EUR Market Closed
Market Cap: €55.8m

Net Margin

10%
Current
Declining
by 0.3%
vs 3-y average of 10.3%

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
10%
=
Net Income
€6.1m
/
Revenue
€61m

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
10%
=
Net Income
€6.1m
/
Revenue
€61m

Peer Comparison

Country Company Market Cap Net
Margin
IT
Shedir Pharma Srl Unipersonale
MIL:SHE
55.4m EUR
Loading...
US
Eli Lilly and Co
NYSE:LLY
1T USD
Loading...
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP
Loading...
US
Johnson & Johnson
NYSE:JNJ
528.7B USD
Loading...
CH
Roche Holding AG
SIX:ROG
275.3B CHF
Loading...
UK
AstraZeneca PLC
LSE:AZN
210.3B GBP
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.8T DKK
Loading...
CH
Novartis AG
SIX:NOVN
221.9B CHF
Loading...
US
Merck & Co Inc
NYSE:MRK
267.9B USD
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
US
Pfizer Inc
NYSE:PFE
145.6B USD
Loading...

Market Distribution

In line with most companies in Italy
Percentile
69th
Based on 1 294 companies
69th percentile
10%
Low
-24 712% — 1.6%
Typical Range
1.6% — 10.1%
High
10.1% — 3 667.8%
Distribution Statistics
Italy
Min -24 712%
30th Percentile 1.6%
Median 5.3%
70th Percentile 10.1%
Max 3 667.8%

Shedir Pharma Srl Unipersonale
Glance View

Market Cap
55.8m EUR
Industry
Pharmaceuticals

Shedir Pharma Group SpA operates as a holding company which engages in the research and development of nutraceuticals and medical devices. The company is headquartered in Mercato San Severino, Salerno and currently employs 71 full-time employees. The company went IPO on 2019-07-23. The firm markets its products in different forms and under the brand lines Shedir Farmaceutici, Deimos Farmaceutici, Phobos Farmaceutici, Menkar Farmaceutici and Greenplanet Divisione Farmaceutica. Its products cover a wide range of therapeutics areas, such as cardiovascular, dermatology, neurology, urology, gynecology and dental health, among others.

SHE Intrinsic Value
Not Available
What is Net Margin?
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
How is Net Margin calculated?

Net Margin is calculated by dividing the Net Income by the Revenue.

Net Margin
10%
=
Net Income
€6.1m
/
Revenue
€61m
What is Shedir Pharma Srl Unipersonale's current Net Margin?

The current Net Margin for Shedir Pharma Srl Unipersonale is 10%, which is below its 3-year median of 10.3%.

How has Net Margin changed over time?

Over the last 3 years, Shedir Pharma Srl Unipersonale’s Net Margin has increased from 8% to 10%. During this period, it reached a low of 8% on May 30, 2021 and a high of 11.1% on Dec 31, 2022.

Back to Top